These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27508489)
21. Serum endocan level and diastolic functions in the case of lead exposure. Kara H; Karakulak UN; Gündüzöz M; Bal C; Alışık M; Büyükşekerci M; İritaş SB; Yılmaz ÖH; Tutkun L Turk J Med Sci; 2019 Feb; 49(1):66-73. PubMed ID: 30761860 [TBL] [Abstract][Full Text] [Related]
22. Endothelial cell-specific-molecule-1 (endocan) levels in women with premature ovarian insufficiency: a prospective comparative study. Ovayolu A; Karaman E; Turgut A; Cekici Y; Ortabag T; Chiara Rapisarda AM; Noventa M; Cianci A J Obstet Gynaecol; 2021 May; 41(4):637-641. PubMed ID: 32808833 [TBL] [Abstract][Full Text] [Related]
23. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension. Wang XS; Yang W; Luo T; Wang JM; Jing YY Genet Test Mol Biomarkers; 2015 Mar; 19(3):124-7. PubMed ID: 25588082 [TBL] [Abstract][Full Text] [Related]
24. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Balta I; Balta S; Demirkol S; Mikhailidis DP; Celik T; Akhan M; Kurt O; Kurt YG; Aydin I; Kilic S Br J Dermatol; 2013 Nov; 169(5):1066-70. PubMed ID: 23889284 [TBL] [Abstract][Full Text] [Related]
25. Elevated endocan concentration is associated with coronary slow flow. Ye MF; Zhao ZW; Luo YK; Dong XF; Yan YM Scand J Clin Lab Invest; 2016 Sep; 76(5):345-8. PubMed ID: 27180882 [TBL] [Abstract][Full Text] [Related]
27. Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients? Ağaç MT; Kahyaoğlu B; Aksoy MMN; Cinemre FB; Vatan MB; Gündüz Y Anatol J Cardiol; 2019 Feb; 21(2):76-82. PubMed ID: 30694799 [TBL] [Abstract][Full Text] [Related]
28. Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study. Bălănescu A; Codreanu IF; Comanici VD; Stan IV; Bălănescu E; Bălănescu P Biomed Res Int; 2020; 2020():2102401. PubMed ID: 32879879 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia. Halawani M Int J Dermatol; 2014 Feb; 53(2):171-7. PubMed ID: 23675675 [TBL] [Abstract][Full Text] [Related]
30. Concentration and value of endocan on outcome in adult patients after severe sepsis. Hsiao SY; Kung CT; Tsai NW; Su CM; Huang CC; Lai YR; Wang HC; Cheng BC; Su YJ; Lin WC; Chiang YF; Lu CH Clin Chim Acta; 2018 Aug; 483():275-280. PubMed ID: 29750963 [TBL] [Abstract][Full Text] [Related]
31. COVID-19 and Endocan Levels. Balta Ş Angiology; 2021 Mar; 72(3):209. PubMed ID: 33086860 [No Abstract] [Full Text] [Related]
32. Imbalanced concentrations of serum lipids and lichen planus. Polić MV; Miskulin M; Solić K; Pluzarić V; Sikora M; Atalić B Coll Antropol; 2014 Jun; 38(2):595-9. PubMed ID: 25144994 [TBL] [Abstract][Full Text] [Related]
33. Relationship between Serum Level of Endocan and Severity of Childhood Asthma. Abdel-Mohsen AH; Allam E Egypt J Immunol; 2018 Jan; 25(1):135-142. PubMed ID: 30243005 [TBL] [Abstract][Full Text] [Related]
34. Serum endocan levels as a marker of disease activity in patients with Behçet disease. Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522 [TBL] [Abstract][Full Text] [Related]
35. Serum endocan levels are increased in patients with inflammatory bowel disease. Voiosu T; Bălănescu P; Benguş A; Voiosu A; Baicuş CR; Barbu M; Ladaru A; Nitipir C; Mateescu B; Diculescu M; Voiosu R Clin Lab; 2014; 60(3):505-10. PubMed ID: 24697130 [TBL] [Abstract][Full Text] [Related]
36. Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients. Oka S; Obata Y; Sato S; Torigoe K; Sawa M; Abe S; Muta K; Ota Y; Kitamura M; Kawasaki S; Hirose M; Uramatsu T; Mukae H; Nishino T Med Sci Monit; 2017 Mar; 23():1464-1470. PubMed ID: 28343234 [TBL] [Abstract][Full Text] [Related]
37. High prevalence of glucose metabolism disturbance in patients with lichen planus. Seyhan M; Ozcan H; Sahin I; Bayram N; Karincaoğlu Y Diabetes Res Clin Pract; 2007 Aug; 77(2):198-202. PubMed ID: 17275122 [TBL] [Abstract][Full Text] [Related]
38. Association of apelin, endoglin and endocan with diabetic peripheral neuropathy in type 2 diabetic patients. Bilir B; Ekiz Bilir B; Yilmaz I; Soysal Atile N; Yildirim T; Kara SP; Gumustas SA; Orhan AE; Aydin M Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):892-8. PubMed ID: 27010147 [TBL] [Abstract][Full Text] [Related]
39. Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease. Lee HG; Choi HY; Bae JS Kidney Int; 2014 Dec; 86(6):1079-81. PubMed ID: 25427083 [TBL] [Abstract][Full Text] [Related]
40. Endocan measurement for the postmortem diagnosis of sepsis. Palmiere C; Augsburger M Leg Med (Tokyo); 2014 Jan; 16(1):1-7. PubMed ID: 24262651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]